pozanicline has been researched along with ADDH in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Childress, A; Sallee, FR | 1 |
| Abi-Saab, WM; Apostol, G; Bensman, L; Childress, A; Garimella, TS; Gault, LM; Hall, CM; Kratochvil, CJ; Olson, E; Robieson, WZ; Saltarelli, MD; Wilens, TE | 1 |
| Franke, AG; Huss, M; Konrad, A; Lieb, K | 1 |
| Abi-Saab, W; Adler, LA; Apostol, G; Collins, MA; Feifel, D; Gault, LM; Kratochvil, CJ; Pritchett, YL; Robieson, WZ; Saltarelli, MD | 1 |
| Abi-Saab, WM; Apostol, G; Bain, EE; McNeill, DL; Robieson, WZ; Saltarelli, MD; Sangal, RB | 1 |
| Adler, LA; Verlinden, MH; West, SA; Wilens, TE; Wozniak, PJ | 1 |
| Decker, MW; Wilens, TE | 1 |
3 review(s) available for pozanicline and ADDH
| Article | Year |
|---|---|
Pozanicline for the treatment of attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Animals; Attention Deficit Disorder with Hyperactivity; Child; Cognition Disorders; Drug Design; Drug Partial Agonism; Humans; Nicotinic Agonists; Pyridines; Pyrrolidines; Receptors, Nicotinic | 2014 |
[Stimulant and non-stimulant medication in current and future therapy for ADHD].
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA | 2012 |
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cognition; Humans; Isoxazoles; Nicotinic Agonists; Pyridines; Pyrrolidines; Receptors, Nicotinic; Synaptic Transmission | 2007 |
4 trial(s) available for pozanicline and ADDH
| Article | Year |
|---|---|
Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Nicotinic Agonists; Propylamines; Psychiatric Status Rating Scales; Pyridines; Pyrrolidines; Treatment Outcome | 2011 |
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Cross-Over Studies; Double-Blind Method; Drug Partial Agonism; Female; Headache; Humans; Irritable Mood; Male; Middle Aged; Nicotinic Agonists; Pyridines; Pyrrolidines; Receptors, Nicotinic; Treatment Outcome | 2012 |
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Partial Agonism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Pyridines; Pyrrolidines; Receptors, Nicotinic | 2012 |
ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study.
Topics: Adult; Attention; Attention Deficit Disorder with Hyperactivity; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Pyridines; Pyrrolidines; Treatment Outcome | 2006 |